Clinical Trial Update: Efficacy and Safety of Estradiol and Progesterone Microspheres for the Treatment of Climacteric Symptoms. [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trials evaluating the efficacy and safety of estradiol and progesterone microspheres for menopausal/climacteric symptoms have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• Estradiol microspheres (estradiol)
• Progesterone microspheres (progesterone (microsphere formulation))

Snippet

Sponsor: Centro A.F. de Estudios Tecnologicos, S.A. | Conditions: Menopause | Phase 2, Phase 3 | Status: COMPLETED